Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

The study will be carried out in partnership with The GOG Foundation and the European Network of Gynaecological Oncological ...

Pāpāmoa retiree Marion Henriksen was meant to be travelling in Germany and Austria with a friend. Instead, she had to cancel ...

Solventum, a global MedTech leader at the forefront of infection prevention innovation, today announced the launch of its Attesttm Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack.

The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...